All filters
Slidesets
Dolutegravir with TB Treatment, How Low is Too Low? | Geraint Rhys Davies
Presented at:
The Liverpool Course 2024
Slidesets
Case 2: Substituting Statins – Same or Different? | Thomas Heseltine
Presented at:
The Liverpool Course 2024
Slidesets
Case 1: Gender Transitioning with ARVs | Tessa Senneker
Presented at:
The Liverpool Course 2024
Videos
Case 2: Substituting Statins – Same or Different? | Thomas Heseltine
Presented at:
The Liverpool Course 2024
Videos
Dolutegravir with TB Treatment, How Low is Too Low? | Geraint Rhys Davies
Presented at:
The Liverpool Course 2024
Videos
Case 1: Gender Transitioning with ARVs | Tessa Senneker
Presented at:
The Liverpool Course 2024
Meeting
The Liverpool Course 2024
Slidesets
Framework for Drug Resistance and Drug Resistance Related Issues - Fengting Yu
Presented at:
The 3rd International Forum on HIV Treatment and Prevention in Asia-Pacific Region
Slidesets
ARV-Based PrEP: Update on the Science and Scale-Up - Benjamin R. Bavinton, PhD, MPH, BA (Hon)
Presented at:
The 3rd International Forum on HIV Treatment and Prevention in Asia-Pacific Region
Slidesets
WHO Strategy for the Prevention, Monitoring, and Response to HIV Drug Resistance - Michael R. Jordan, MD, MPH
Presented at:
The 3rd International Forum on HIV Treatment and Prevention in Asia-Pacific Region
Slidesets
HIV Drug Resistance to Current New Antiretroviral Drugs - Hongxin Zhao, MD, MPH
Presented at:
The 3rd International Forum on HIV Treatment and Prevention in Asia-Pacific Region
Slidesets
Challenge of Translating PEP & PrEP from Research to Practice in China - Hui Wang, MD
Presented at:
The 3rd International Forum on HIV Treatment and Prevention in Asia-Pacific Region
Slidesets
Non Drug PrEP - Ishwar Gilada, MD, DDV, FCPS
Presented at:
The 3rd International Forum on HIV Treatment and Prevention in Asia-Pacific Region